Advanz Pharma, 7% 15apr2023 (USC26215AA88)

Name: International bonds: Advanz Pharma, 7% 15apr2023 (USC26215AA88)
Creator: Cbonds
License: https://creativecommons.org/licenses/by/4.0/

Download

Copy issue information to clipboard

Copy to clipboard

Data copied to the clipboard

PDF download

Choose all Reset all

Download Cancel

Default

International bonds, Senior Unsecured

Status

Early redeemed

Amount

735,000,000 USD

Placement

***

Early redemption

*** (-)

ACI on

Country of risk

Canada

Current coupon

Price

Yield / Duration

Calculate in two clicks! yield, duration and other parameters

Calculator

What is a calculator?

Placement amount

735,000,000 USD
Outstanding amount

735,000,000 USD
Minimum Settlement Amount

2,000 USD
ISIN RegS

USC26215AA88
CFI RegS

DBFUGR
FIGI RegS

BBG008H4S978
Ticker

ADVZCN 7 04/15/23 REGS

explore the most comprehensive database

800 000

bonds globally

Over 400

pricing sources

80 000

stocks

116 000

ETF & Funds

track your portfolio in the most efficient way

Bond Search
Watchlist
Excel ADD-IN

Get access

— Are you looking for the complete & verified bond data?

— We have everything you need:

full data on over 800 000 bonds, 80 000 stocks, 116 000 ETF & Funds; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.

Why

You will have detailed descriptive & pricing data for 650K bonds, 76K stocks, 8K ETFs

Get full access to the platform from any device & via Cbonds app

Enhance your portfolio management with Cbonds Excel Add-in

Build yield maps, make chart comparison within a click

Don't wait any longer — start using Cbonds today! Register

Trading chart

Stock exchange selection

More about Cbonds Estimation

Bond is not traded; the issue is redeemed

Data display in a chart | table

Work with the chart: switching the price, period, issue comparison

Customize fields in the table

Found:

Show all fields

from

ADD-IN
Cbonds add-in API
bond data api

Authorization required

You need to request access

* Data is not available within the selected subscription

Issue information

Profile

Advanz Pharma Corp. (formerly Concordia International Corp.) operates a healthcare business that includes the management and acquisition of legacy pharmaceutical products and acquires and develops orphan drugs both with patent life and exclusivity remaining (pre-legacy), and products that have reached full maturity but continue on a predictable revenue generation path, collectively referred to as legacy products.

Show more Hide

Research report by Cbonds-PRAAMS

Save

Authorization required

Report download is available only paid Premium subscription access

Borrower

Go to the issuer page
Advanz Pharma
Full borrower / issuer name

Advanz Pharma
Sector

Corporate
Industry

Pharmaceutical Preparation and Biotechnology

Volume

Placement amount

735,000,000 USD
Outstanding amount

735,000,000 USD

Face value

Minimum Settlement Amount

2,000 USD
Outstanding face value

*** USD
Increment

*** USD
Face value

1,000 USD

Listing

Listing

***

Cash flow parameters

Reference rate

***

Coupon Rate

***

Day count convention

***

Interest Accrual Date

***

Coupon frequency

*** time(s) per year
Payment currency

***
Maturity date

***
Early redemption date

***

Cash flow

Calculations for international bonds are made according to the minimum trading lot

Export to Excel

Early redemption terms

***

Debt Servicing

explore the most comprehensive database

800 000

bonds globally

Over 400

pricing sources

80 000

stocks

116 000

ETF & Funds

track your portfolio in the most efficient way

Bond Search
Watchlist
Excel ADD-IN

Get access

— Are you looking for the complete & verified bond data?

— We have everything you need:

Why

You will have detailed descriptive & pricing data for 650K bonds, 76K stocks, 8K ETFs

Get full access to the platform from any device & via Cbonds app

Enhance your portfolio management with Cbonds Excel Add-in

Build yield maps, make chart comparison within a click

Don't wait any longer — start using Cbonds today! Register

Placement

Placement method

Open subscription
Placement type

Public
Placement

***
Initial issue price (yield)

(***%)
Geographic breakdown

***
Investor breakdown

***

Participants

Bookrunner

***, ***, ***

Conversion and exchange

Conversion terms

***

Additional information

Latest issues

Show all

Similar issues

News

30/09/2021	S&P Global Ratings withdrew Local Currency LT credit rating for Advanz Pharma
30/09/2021	S&P Global Ratings withdrew Foreign Currency LT credit rating for Advanz Pharma
14/09/2018	Moody's Investors Service withdrew LT- foreign currency credit rating for Concordia International
01/08/2018	S&P Global Ratings upgrades Local Currency LT credit rating of Concordia International to "B-" from "D"; outlook stable
01/08/2018	S&P Global Ratings upgrades Foreign Currency LT credit rating of Concordia International to "B-" from "D"; outlook stable

All organization news

IFRS/US GAAP reports

2017



	IV q eng

Authorization required

You need to request access

Identifiers

ISIN RegS

***
Cbonds ID

140031
ISIN 144A

***
CUSIP RegS

***
CUSIP 144A

***
CFI RegS

DBFUGR
CFI 144A

DBFUGR
FIGI RegS

BBG008H4S978
FIGI 144A

BBG008GC17Z3
WKN RegS

A1Z0FU
WKN 144A

A1ZZ6Y
Ticker

ADVZCN 7 04/15/23 REGS
Type of security by CBR

***

Show more Hide

Bond classification

Senior Unsecured
Registered
Coupon bonds
Amortization
Callable
CDO
Convertible
Dual currency bonds
Variable rate
For qualified investors (CIS region)
Foreign bonds
Green bonds
Guaranteed
Inflation-linked principal
Supranational bond issues
Inflation-linked coupon
Mortgage bonds
Non-complex financial instruments (MiFID)
Perpetual
Payment-in-kind
Non-Marketable Securities
Redemption Linked
Restructuring
Retail bonds
Covered
Securitization
Structured product
Commercial Bonds
Subordinated
Sukuk
Trace-eligible

Show more Hide

Restructuring

***